Literature DB >> 11745629

Activation of prostanoid EP(3) and EP(4) receptor mRNA-expressing neurons in the rat parabrachial nucleus by intravenous injection of bacterial wall lipopolysaccharide.

D Engblom1, M Ek, A Ericsson-Dahlstrand, A Blomqvist.   

Abstract

Systemic inflammation activates central autonomic circuits, such as neurons in the pontine parabrachial nucleus. This activation may be the result of afferent signaling through the vagus nerve, but it may also depend on central prostaglandin-mediated mechanisms. Recently, we have shown that neurons in the parts of the parabrachial nucleus that are activated by immune challenge express prostaglandin receptors of the EP(3) and EP(4) subtypes, but it remains to be determined if the prostaglandin receptor-expressing neurons are identical to those that respond to immune stimuli. In the present study, bacterial wall lipopolysaccharide was injected intravenously in adult male rats and the expression of c-fos mRNA and of EP(3) and EP(4) receptor mRNA was examined with complementary RNA probes labeled with digoxigenin and radioisotopes, respectively. Large numbers of neurons in the external lateral parabrachial subnucleus, a major target of vagal-solitary tract efferents, expressed c-fos mRNA. Quantitative analysis showed that about 60% (range 40%-79%) of these neurons also expressed EP(3) receptor mRNA. Conversely, slightly more than 50% (range 48%-63%) of the EP(3) receptor-expressing neurons in the same subnucleus coexpressed c-fos mRNA. In contrast, few EP(4) receptor-expressing neurons were c-fos positive, with the exception of a small population located in the superior lateral and dorsal lateral subnuclei. These findings show that immune challenge activates central autonomic neurons that could be the target of centrally produced prostaglandin E(2), suggesting that synaptic signaling and paracrine mechanisms may interact on these neurons. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745629     DOI: 10.1002/cne.1391

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  6 in total

1.  Fos-activation of FoxP2 and Lmx1b neurons in the parabrachial nucleus evoked by hypotension and hypertension in conscious rats.

Authors:  R L Miller; M M Knuepfer; M H Wang; G O Denny; P A Gray; A D Loewy
Journal:  Neuroscience       Date:  2012-05-26       Impact factor: 3.590

2.  Neural controls of prostaglandin 2 pyrogenic, tachycardic, and anorexic actions are anatomically distributed.

Authors:  Karolina P Skibicka; Amber L Alhadeff; Theresa M Leichner; Harvey J Grill
Journal:  Endocrinology       Date:  2011-03-29       Impact factor: 4.736

3.  Neurobiology of inflammation-associated anorexia.

Authors:  Laurent Gautron; Sophie Layé
Journal:  Front Neurosci       Date:  2010-01-08       Impact factor: 4.677

4.  Inducible prostaglandin E2 synthesis interacts in a temporally supplementary sequence with constitutive prostaglandin-synthesizing enzymes in creating the hypothalamic-pituitary-adrenal axis response to immune challenge.

Authors:  Louise Elander; Linda Engström; Johan Ruud; Ludmila Mackerlova; Per-Johan Jakobsson; David Engblom; Camilla Nilsberth; Anders Blomqvist
Journal:  J Neurosci       Date:  2009-02-04       Impact factor: 6.167

5.  GLP-1 receptor stimulation of the lateral parabrachial nucleus reduces food intake: neuroanatomical, electrophysiological, and behavioral evidence.

Authors:  Jennifer E Richard; Imre Farkas; Fredrik Anesten; Rozita H Anderberg; Suzanne L Dickson; Fiona M Gribble; Frank Reimann; John-Olov Jansson; Zsolt Liposits; Karolina P Skibicka
Journal:  Endocrinology       Date:  2014-08-13       Impact factor: 4.736

6.  Alterations of voluntary behavior in the course of disease progress and pharmacotherapy in mice with collagen-induced arthritis.

Authors:  Yohsuke Oto; Yukari Takahashi; Daitaro Kurosaka; Fusao Kato
Journal:  Arthritis Res Ther       Date:  2019-12-12       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.